CTEV Stock Summary and Trading Ideas (Claritev Class A | NYSE:CTEV)

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Claritev Class A trades on the NYSE stock market under the symbol CTEV.

As of October 13, 2026, CTEV stock price declined to $23.72 with 118,907 million shares trading.

CTEV has a beta of 2.26, meaning it tends to be more sensitive to market movements. CTEV has a correlation of 0.03 to the broad based SPY ETF.

CTEV has a market cap of $401.99 million. This is considered a Small Cap stock.

Last quarter Claritev Class A reported $257 million in Revenue and -$3.49 earnings per share. This beat revenue expectation by $12 million and missed earnings estimates by -$3.73.

The top ETF exchange traded funds that CTEV belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWN.

CTEV has underperformed the market in the last year with a return of -55.9%, while the SPY ETF gained +18.5%. In the last 3 month period, CTEV fell short of the market, returning -24.1%, while SPY returned +4.1%. However, in the most recent 2 weeks CTEV has outperformed the stock market by returning +5.6%, while SPY returned +1.8%.

CTEV support price is $22.80 and resistance is $25.86 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.